Alperen Sengun relieves Rockets by avoiding surgery after scary injury

Turkish center Alperen Sengun escapes more serious injury after frightening fall against the Kings, but may end up no longer playing this season

Unfortunately, Alperen Sengun may no longer take the court in the 2023/24 season due to Houston Rockets. However, the Turk avoided a major injury and will not need to undergo surgery. The pivot, who is the highlight of the Texas franchise’s campaign, suffered a frightening injury in the team’s victory against Sacramento Kingslast Sunday, the 10th, needing to leave the platform in a wheelchair.

According to the journalist Adrian Wojnarowski, from the North American “ESPN”, Sengun suffered a serious sprain in his right ankle and a bone injury in his right foot. However, he avoided an even worse leg injury. When the play happened, the general idea was that the Turk must have fractured his ankle or had a knee ligament injury, or even both. But none of that happened.

“Right after leaving the court, he underwent an x-ray. This Monday, he had an MRI. The procedures then confirmed that he did not need surgery. In other words, as far as possible, this is the best news for Houston.”said the behind-the-scenes reporter from NBA. However, Woj does not rule out the possibility of the young star being out of the current season. With few games still to be played and a distant possibility of reaching the play-in, the Rockets can focus on recovering the athlete.

“At the moment, there is no return period. He is not ruled out to play again in 2023/24. However, this will require a very quick recovery. So nothing official about it. It’s not likely, but he could still play games at the end of the campaign. That’s what some people close to me told me. The great news is that surgery will not be necessary, which prevents the Rockets from losing Alperen Sengun in the long term.”Woj said.


Source: sportbuzz

Related articles

Comments

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share article

Latest articles

Newsletter

Subscribe to stay updated.